Pancreatic Disease and CFRT Modulators: Dr. Katie Larson Ode (Video) episode artwork

EPISODE · Dec 17, 2024 · 42 MIN

Pancreatic Disease and CFRT Modulators: Dr. Katie Larson Ode (Video)

from The CFRI CF Community Voices Podcast

In this podcast, Katie Larson Ode, MD, Pediatric Endocrinology and Diabetes, discusses cystic fibrosis related diabetes (CFRD) which is the most common non-pulmonary complication among people with cystic fibrosis (CF). Dr. Larson Ode offers a better understanding of CFRD as this form of diabetes is unique to CF and is different from type 1 and type 2 diabetes. Dr. Larson Ode also shares the latest studies on how cystic fibrosis transmembrane conductance regulator (CFTR) corrective therapies could treat CFRD. This presentation was recorded at CFRI’s 2024 CF Adult Retreat. Click here to donate to CFRI and support the cystic fibrosis community worldwide: https://cfri.app.neoncrm.com/forms/donation CF Community Voices is made possible through support from Viatris, Vertex Pharmaceuticals, and Gilead Sciences.

Episode metadata supplied by the publisher feed · Published Dec 17, 2024

Embed this episode

NOW PLAYING

Pancreatic Disease and CFRT Modulators: Dr. Katie Larson Ode (Video)

0:00 42:19

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The CFRI CF Community Voices Podcast?

This episode is 42 minutes long.

When was this The CFRI CF Community Voices Podcast episode published?

This episode was published on December 17, 2024.

Can I download this The CFRI CF Community Voices Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!